Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus Infection
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1329
https://www.valueinhealthjournal.com/article/S1098-3015(15)01386-8/fulltext
Title :
Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus Infection
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01386-8&doi=10.1016/j.jval.2015.03.1329
First page :
A228
Section Title :
Infection
Open access? :
No
Section Order :
789